Wutah pendapatan kuartal marang kuartal: Femasys (FEMY)

Simbol resmi perusahaan Femasys Corporation (FEMY)

Femasys Inc. is transitioning from clinical trials to market expansion, reducing its reliance on a single product. The company's quarterly revenue growth on the GURU.Markets base chart reflects this trend, where the value -44.80 represents the metric balance. This growth is driven by the robotization of women's health diagnostics and the implementation of minimally invasive systems for infertility treatment, which diversifies the medical instrument portfolio.

FEMY (Femasys Corp) riwayat Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 20.11.2026

Femasys Inc (FEMY) - rincian metrik lan laporan keuangan

Analisis fundamental perusahaan:Femasys Corp (FEMY)
Barang unggulan Femasys

Femasys Inc. (FEMY) development of needle-free diagnostic and contraceptive methods defines the business's scaling potential through the accessibility of medical procedures. This trend is reflected in the calculation of the percentage change in revenue between the current and corresponding previous quarter, allowing investors to assess demand cyclicity and the sustainability of commercial growth by analyzing the quarterly sales growth rate.

Pesaing wigati

ISRG: Wutah dodolan triwulanan|Danaher Corp. (DHR) - Wutah dodolan triwulanan|BDX: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal STERIS PLC (STE)|Wutah pendapatan kuartal marang kuartal West Pharmaceutical Services|Wutah dodolan kuartal marang kuartal BAX (Baxter International)|Wutah pendapatan kuartal marang kuartal Masimo (MASI)|Stevanato Group - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Teleflex Inc. TFX|Owah-owahan dodolan kuartal marang kuartal MMSI (Merit Medical Systems, Inc.)|NVST - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal ICU Medical Corp ICUI|XRAY: Wutah pendapatan triwulanan|LMAT (LeMaitre Vascular, Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan ATRC|STAA (STAAR Surgical) - Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal ChromaDex (NAGE)|Wutah dodolan triwulanan ZimVie Inc. ZIMV|Wutah pendapatan triwulanan ANGO (angiodynamics.com)|Wutah pendapatan triwulanan cerus.com CERS|teknova.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal KORU Medical Systems KRMD|Wutah pendapatan kuartal marang kuartal Nyxoah SA (NYXH)|Owah-owahan dodolan kuartal marang kuartal MBOT|Wutah pendapatan triwulanan PDEX (Pro-Dex Inc.)|Owah-owahan dodolan kuartal marang kuartal ZTEK (Zentek Limited)|elutia.com - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Wutah dodolan triwulanan|Retractable Technologies - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal harvardbioscience.com|Wutah pendapatan triwulanan MeihuaMed|Wutah pendapatan kuartal marang kuartal Predictive Oncology Corp (POAI)|Callan JMB - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan ATRI (atrioncorp.com)|NURO: Wutah dodolan kuartal marang kuartal